
    
      Randomized, sham-controlled, double-blind study for acute migraine attacks.

      Treatment Phase:

      • ≤60 days to present at clinic for treating up to 2 migraines (at least 48 hours apart).
      First treatment is randomized between active treatment and sham treatment. Second optional
      treatment is open-label.

      Post-Treatment Follow-up Phase:

        -  24 hours after initiating treatment, for each of up to two migraine treatments, for
           conducting post-treatment follow-up assessments of migraine symptoms.

        -  30, 60, and 90 days following the first migraine treatment for migraine diary
           assessments (and MIDAS assessment at 90 days)

      Collection of migraine diaries at 30, 60, & 90 days post enrollment. Collection of MIDAS data
      at 60 and 90 days post treatment.
    
  